ARQT
Arcutis Biotherapeutics, Inc. · Healthcare
Director Terrie Curran sold $94K of Arcutis Biotherapeutics, Inc.
Sold$94,238
$10.85Price
8,687Shares
−46%Stake
What ARQT did after the filing
- The stock from Wed, Nov 13 close, $10.47
- +36.6%
- S&P 500, same days
- 0.0%
Measured over 30 trading days, to the Dec 27 close.
Traded Mon, Nov 11. Filed Wed, Nov 13, 1:45 PM ET, during the session. Returns use the Nov 13 close and the Dec 27 close. Not investment advice.